ORX:STO
Orexo AB
0,88 SEK
arrow_upward
+1,27%(+0,011) 1D
13 қар., 17:29:57 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
308,06 млн
Avg. vol.
739,90 м.
Volume
0,00
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
308,06 млн
Avg. vol.
739,90 м.
Volume
0,00
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
TradingView
·
7 сағат бұрын
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
3 сағат бұрын
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
12 сағат бұрын
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Traders Union
·
7 сағат бұрын
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com